Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
Khan
M A
MA
Department of Medicine, The Aga Khan University Hospital, Karachi.
Siddiqui
B K
BK
Shamim
A
A
Yosuf
M A
MA
Ahmed
U
U
Zakiullah
N
N
Burney
I A
IA
D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D003023:Cloxacillin / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D006090:Gram-Negative Bacteria / Q000187:drug effects / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000187:drug effects / Q000302:isolation & purification; D019337:Hematologic Neoplasms / Q000150:complications*; D006785:Hospitals, University; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D007938:Leukemia / Q000150:complications; D008826:Microbial Sensitivity Tests; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology; D010154:Pakistan; D012189:Retrospective Studies; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014640:Vancomycin; D015378:Imipenem; D000583:Amikacin; D003023:Cloxacillin